ClinicalTrials.Veeva

Menu

Walnut and Immunity Study (walnutimmune)

Loma Linda University (LLU) logo

Loma Linda University (LLU)

Status

Completed

Conditions

Immune Response
Upper Respiratory Tract Infection

Treatments

Dietary Supplement: Habitual diet
Dietary Supplement: walnuts

Study type

Interventional

Funder types

Other

Identifiers

NCT05915390
5220423

Details and patient eligibility

About

The main objective of the study is to determine if eating walnuts enhances immune function, in older free-living men and postmenopausal women with overweight.

Full description

The main objectives of our proposed study are to determine the effect of walnut consumption on innate, acquired, and gut immunity by assessing whether the ingestion of walnuts enhances immune function, in older free-living men and postmenopausal women with overweight. To accomplish these objectives, a randomized controlled, parallel design study is proposed with two groups consuming their habitual diet, but with one (Walnut group) receiving 15% of their total energy as walnuts and the other (Control group) abstaining from eating any walnuts and limited amounts of other tree nuts and peanuts (up to <1 serving/wk).

Enrollment

52 patients

Sex

All

Ages

55 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Older men and post-menopausal women aged 55-75 years
  • Have a BMI of 25-32
  • Being able to commute to Loma Linda University.
  • Not taking medication or supplements that affect immunity

Exclusion criteria

  • Intolerance or allergy to walnuts
  • Regular intake of walnuts and/or other nuts (>3 ounces per week).
  • Immune system insufficiency or disease.
  • Using immune boosting supplements.
  • Exposure to antibiotics and corticoids immediately prior to the study.
  • Participants with uncontrolled chronic diseases, and relevant psychiatric illness, including major depression will not be included in study
  • Flu vaccination or Covid booster within past 6 months

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

52 participants in 2 patient groups

walnut group
Active Comparator group
Description:
walnut group will receive 15% of their total energy as walnuts
Treatment:
Dietary Supplement: walnuts
control group
Active Comparator group
Description:
continue with habitual diet and abstain from eating walnuts
Treatment:
Dietary Supplement: Habitual diet

Trial contacts and locations

1

Loading...

Central trial contact

Amandeep Kaur, MPH; Joan Sabate, DrPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems